12
Participants
Start Date
September 30, 2014
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
(+)-Epicatechin
The drug to be tested is (+)-epicatechin, synthesized under GMP standards. Subjects will be given a single oral dose of (+)- epicatechin and followed on an inpatient basis over 24 hours. Three (3) different dose levels will be tested in a randomized, double-blind design: (+)- epicatechin 10 mg, 30 mg, or 100 mg. As this is a pilot study, a placebo arm will not be included.
VA San Diego Healthcare System, San Diego
National Institutes of Health (NIH)
NIH
National Center for Complementary and Integrative Health (NCCIH)
NIH
San Diego Veterans Healthcare System
FED
University of California, San Diego
OTHER
Veterans Medical Research Foundation
OTHER